An observational cohort study of hydroxychloroquine and azithromycin for COVID-19: (Can’t Get No) Satisfaction
Todd C. Lee, Lauren J MacKenzie, Emily G. McDonald, Steven Y. C. Tong
Abstract
It is clear that SARS-CoV-2 caught the world by surprise. In large part due to globalization, the virus quickly evolved from a serious regional concern to a worldwide pandemic, the likes of which are unprecedented in the last century. In a matter of weeks, COVID-19 became a leading cause of death in 2020, with a staggering potential death toll. Due to a heavy burden of illness, and in the absence of proven therapies, several experimental treatments have been, and continue to be, prescribed outside of clinical trial settings.
Topics & Concepts
Death tollHydroxychloroquinePandemicSurpriseAzithromycinCoronavirus disease 2019 (COVID-19)MedicineObservational studyTollSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort2019-20 coronavirus outbreakGlobalizationIntensive care medicineVirologyEnvironmental healthInternal medicineOutbreakPsychologyPolitical scienceImmunologyDiseaseBiologyAntibioticsLawInfectious disease (medical specialty)Social psychologyMicrobiologyCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research